WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) released the below statement today following the adoption of Kentucky House Bill 386 into law, legislation that will eliminate the state’s annual purchase limit for common over-the-counter (OTC) cold and allergy medications containing the ingredient pseudoephedrine (PSE), which is currently the most restrictive yearly limit nationwide at 24
WASHINGTON – The Consumer Healthcare Products Association (CHPA) has appointed Lisa Parks to serve as its senior vice president of regulatory & scientific affairs. Parks will succeed Barbara Kochanowski, who is retiring in July after nearly four decades of regulatory leadership in the consumer healthcare industry. Parks will begin her work at CHPA on June
WASHINGTON — The Consumer Healthcare Products Association (CHPA) released the following statement in advance of FDA Advisory Committee meetings considering OTC access to naloxone: “Over-the-counter (O-T-C) availability of naloxone – a life-saving emergency therapy for opioid overdoses that is currently only available with a prescription (Rx) – would be a critical step forward in public
In the second installment of a two-part interview, Scott Melville, president and chief executive officer of the Consumer Healthcare Products Association, discusses the regulatory environment for health care devices and dietary supplements (two areas where CHPA has recently stepped up its involvement); state-level issues affecting suppliers; and the value that O-T-Cs bring to consumers at
WASHINGTON – The Consumer Healthcare Products Association (CHPA) announced Lisa Paley as chair-elect of the CHPA board of directors. Paley will assume the position of board chair in March 2023, when current CHPA board chair Michelle Goodridge, president, U.S. Self Care, Johnson & Johnson Consumer, Inc. concludes her chairmanship. CHPA also welcomes two new manufacturer
NEW HOPE, Pa. – The Consumer Healthcare Products Association (CHPA) has awarded its Ivan D. Combe Lifetime achievement award to longtime industry leader Scott Emerson. This annual award – the highest honor bestowed by the U.S. consumer healthcare industry – recognizes the outstanding work and contributions of individuals whose actions have created a lasting impact
WASHINGTON – The Consumer Healthcare Products Association (CHPA) has launched a new podcast – CHPA Chat – providing stories and insights from staff, industry leaders, academics, and health care providers about the trends and issues facing the consumer healthcare space. Hosting the podcast is Anita Brikman, senior vice president, Communications & Public Affairs, and executive director,
WASHINGTON — Four of the leading trade organizations representing the dietary supplement industry are commemorating the 100th meeting of the Dietary Supplement Trade Associations (DSTA). More than ten years ago, the American Herbal Products Association (AHPA), the Consumer Healthcare Products Association (CHPA), the Council for Responsible Nutrition (CRN), and the United Natural Products Alliance (UNPA) began
The latest installment in our Video Forum features Scott Melville, president and chief executive officer of the Consumer Healthcare Products Association. In addition to the rebranding of CHPA, Melville talks about what recently enacted O-T-C monograph reform means for the category, and the increasingly important part that nonprescription products are playing in health care.
WASHINGTON — Over-the-counter (O-T-C) medicines save the U.S. health care system nearly $146 billion a year, a new study has found. The report, “Value of O-T-C Medicines to the U.S. Healthcare System,” which was released by the Consumer Healthcare Products Association (CHPA), found that, on average, each dollar spent on O-T-Cs saves the national system